Health care stocks were flat to lower premarket Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was recently down 0.3%.
ImmunoPrecise Antibodies (IPA) shares rallied past 14% after the company announced a strategic partnership with an unnamed biotechnology company to discover and develop antibody-drug conjugates and bispecific antibodies to treat cancer.
Integer Holdings (ITGR) shares were down nearly 2% amid plans to offer $750 million of convertible notes due 2030.
Tarsus Pharmaceuticals (TARS) shares were almost 3% lower after the company priced an upsized underwritten public offering of 2.8 million shares at $44.50 per share for gross proceeds of about $125 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。